FOXO4-DRI (15mg)
FOXO4-DRI (15mg)
This research vial contains FOXO4-DRI, a peptide inhibitor studied for its potential to target senescent cells and promote healthy cellular turnover. Researchers have investigated FOXO4-DRI in preclinical studies for its involvement in aging mechanisms, DNA repair, and tissue renewal pathways.
Blend Composition (Per Vial):
FOXO4-DRI – 15mg
Key Characteristics:
-
FOXO4-DRI: Synthetic peptide studied for senolytic and anti-aging effects
-
Explored for its influence on cellular regeneration and apoptosis signaling
-
Sterile peptide vial designed for accurate reconstitution and consistent use
-
Stable formulation supports reproducibility in longevity and aging research
Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.